-
Georgette and John Heerwagen
Georgette and John Heerwagen recently renewed their support for lung cancer research at Dana-Farber with a generous gift of $125,000. Under the direction of David Jackman, MD, in collaboration with David Barbie, MD, both faculty in the Lowe Center for Thoracic Oncology at Dana-Farber, this funding will enable researchers to continue advancing pioneering studies into…
-
Furthering research into new treatment for Waldenstrom’s macroglobulinemia
More than 10 years ago, Steven Treon, MD, PhD, and his colleagues were the first scientists to discover that MYD88 mutations, which occur in more than 95% of patients with Waldenström’s macroglobulinemia (WM), rely on the BTK protein to function.
-
Kendall Family prioritizes innovation in pancreatic cancer
In cancer research, hope can be realized in how we innovate. Inventive clinical trials can lead to novel approaches and new, accessible medicines that ultimately bring better outcomes to patients.
-
The Mark Foundation spurs innovation in immunotherapy
The Mark Foundation for Cancer Research has awarded Dana-Farber investigator Catherine Wu, MD, and two investigators at the Broad Institute a $3 million, three-year grant to further their research into personalized, T cell-directed cancer immunotherapy.
-
Investment in infrastructure accelerates immunotherapy development
The Massachusetts Life Sciences Center (MLSC) has granted Dana-Farber $2.78 million to build crucial infrastructure for developing immunotherapies—novel treatments that leverage the immune system to fight cancer.
-
The Paula and Rodger Riney Foundation sustains momentum in multiple myeloma research
Multiple myeloma treatments have significantly improved over the past two decades, thanks in part to the driving engine of transformational philanthropy.
-
Prevention is goal of groundbreaking immunotherapy trial
When asked what motivates her to support cancer research, Susan Hertog starts at the beginning, when her best friend was diagnosed with metastatic breast cancer at the age of 49.
-
Pan-Mass Challenge raises record $72 million to bring cures closer by the mile
On long journeys, landmarks and milestones show us where we are and how far we’ve come. Since 1980, the Pan-Mass Challenge (PMC), the beloved bike-a-thon and the nation’s most successful athletic fundraiser, has seen plenty of both.
-
Radical collaborations target intractable cancers
BTC has awarded $22.9 million in grants to Dana-Farber researchers working across multiple institutions to unlock the secrets of four difficult-to-treat cancers and intercept or develop cutting-edge treatments for them.
-
Belfers aim to make immunotherapy effective for more patients
An extraordinary gift of $10 million from Robert and Renée Belfer and family will support innovative immuno-oncology research at Dana-Farber.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.